Synthetic Biology Market was estimated to be USD 13.1 billion in 2022, with a projected growth to reach USD 52.6 billion by 2030, reflecting a compound annual growth rate (CAGR) of 19.0% during the forecast period from 2023 to 2030.
Synthetic biology, a rapidly expanding field, is poised to revolutionize various industries through its innovative applications. With the market expected to experience significant growth over the next decade, it presents lucrative opportunities for investors and stakeholders.
The estimated market size of USD 13.1 billion in 2022 highlights the existing demand and adoption of synthetic biology solutions across diverse sectors. As the field continues to evolve and gain traction, the market is projected to witness substantial expansion, reaching a staggering USD 52.6 billion by 2030.
This impressive growth can be attributed to several factors. Firstly, the increasing need for sustainable and eco-friendly solutions in industries such as healthcare, agriculture, and energy has propelled the demand for synthetic biology. By harnessing the power of genetic engineering and biotechnology, synthetic biology offers the potential to develop novel drugs, enhance crop yields, and create renewable energy sources.
Furthermore, the rising investments in research and development activities, coupled with advancements in technology, are driving the market's growth. Governments, private organizations, and academic institutions are actively investing in synthetic biology research, fostering innovation and driving the commercialization of new products and services.
The forecasted compound annual growth rate (CAGR) of 19.0% during the period from 2023 to 2030 underscores the market's potential for substantial expansion. This growth rate signifies the increasing adoption of synthetic biology solutions and the growing market demand for its transformative applications.
In conclusion, the Synthetic Biology Market is poised for remarkable growth, with an estimated value of USD 13.1 billion in 2022, projected to reach USD 52.6 billion by 2030. The field Advancements in synthetic biology are expected to revolutionize various industries, including healthcare, agriculture, and energy, driving the market's exponential growth in the coming years.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/3955
KEY MARKET SEGMENTATION:
By Technology
- NGS Technology
- PCR Technology
- Genome Editing Technology
- Bioprocessing Technology
- Other Technologies
By Product
- Oligonucleotide/Oligo Pools and Synthetic DNA
- Enzymes
- Cloning Technologies Kits
- Xeno-Nucleic Acids
- Chassis Organism
By Application
- Healthcare
- Clinical
- Non-Clinical
- Non-healthcare
- Biotech Crops
- Specialty Chemicals
- Bio-fuels
- Others
By End User
- Biotechnology and Pharmaceutical Companies
- Academic and Government Research Institutes
- Others
Major Players Listed in the Report are as Follows:
Bota Biosciences Inc., Codexis, Inc., Creative Biogene., Creative Enzymes., Enbiotix, Inc., Illumina, Inc., Merck Kgaa (Sigma-Aldrich Co. Llc), New England Biolabs, Euro fins Scientific, Novozymes, Pareto Bio, Inc., Synthetic Genomics Inc., Thermo Fisher Scientific, Inc., and Others.
Other Reports You May Like:
Hormone Replacement Therapy Market Size
Hepatitis B Vaccine Market Size
About US:
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Contact Us:
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),
Website: https://www.snsinsider.com
Comments